NCT06790420 2025-05-31
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
Clinical Trials
23 trialsNCT05923879 2023-06-28
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
Ruijin Hospital
Unknown
NCT02536664 2023-04-18
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Hoffmann-La Roche
Completed
NCT05690191 2023-01-19
Chidamide in Patients With Recurrent and Refractory Diffuse Large b
Second Affiliated Hospital of Soochow University
Enrolling by invitation
NCT03545035 2022-05-12
LLC178
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT03289182 2021-01-11
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)
Hoffmann-La Roche
Completed
NCT02491398 2020-10-06
LLC1315
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04127916 2020-03-18
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Samsung Medical Center
Unknown
NCT03582098 2019-04-12
RETRO-idel
Gilead Sciences
Completed
NCT01178086 2018-10-05
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Hoffmann-La Roche
Completed
NCT01609023 2018-06-26
CaLLypso
Hoffmann-La Roche
Completed
NCT02732236 2018-04-18
Marginal Zone Lymphoma Cohort in Korea
Dong-A University Hospital
Unknown
NCT01684865 2017-12-29
An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's Lymphoma
Hoffmann-La Roche
Completed
NCT02472756 2017-08-01
REFLECT 2
Hoffmann-La Roche
Completed
NCT01406782 2017-05-17
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
Eastern Cooperative Oncology Group
Completed
NCT01224093 2016-11-02
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
Hoffmann-La Roche
Completed
NCT01072240 2016-11-01
An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Completed
NCT01144754 2016-07-01
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Stanford University
Terminated
NCT02316613 2016-02-25
Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
Hoffmann-La Roche
Completed
NCT02461290 2015-09-30
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Hoffmann-La Roche
Completed
NCT02156726 2014-06-05
Q-lite
Czech CLL Study Group
Unknown
NCT00301301 2010-01-12
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Royal Marsden NHS Foundation Trust
Completed
NCT00429065 2007-01-31
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
Instituto Nacional de Cancerologia de Mexico
Unknown